Acinetobacter baumannii is a formidable global pathogen notorious for its widespread drug-resistant nature. It is a major culprit in various infections, particularly targeting immunocompromised individuals in intensive care units (ICUs). A paramount concern associated with this pathogen lies in its remarkable ability to develop resistance to nearly all clinically utilized antibiotics. Furthermore, it exhibits a concerning propensity to disseminate this resistance rapidly, transcending borders and impacting healthcare facilities across diverse economic strata.
Of particular focus is the carbapenem-resistant strain of A. baumannii (CRAb). This strain has garnered the top spot on the World Health Organization's (WHO) list of pathogens, necessitating urgent attention for new treatment development. This book delves into numerous studies underscoring the pivotal role of A. baumannii as one of the most impactful bacteria contributing to Healthcare-Associated Infections (HAIs) within the contemporary healthcare landscape.